O-GlcNAcylation is a post-translational dynamic modification of proteins that is becoming more widely recognized as a modification that can protect proteins from pathological aggregation in neurodegenerative diseases. However, it...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
OMRP
O-Glc-NAc modifications of RNA-binding proteins
169K€
Cerrado
UNDERPIN
Untranslated regions of RNAs and protein networks in patholo...
173K€
Cerrado
NEVULA
Understanding selective neuronal vulnerability in Alzheimer...
247K€
Cerrado
ExItALS
RNA mediated intercellular miscommunication role of extrace...
180K€
Cerrado
NEUROGLIOSOLVE
RNA biology and neuroglial function: resolving the cellular...
196K€
Cerrado
RIBOMYLOME
The Role of Non coding RNA in Protein Networks and Neurodege...
1M€
Cerrado
Información proyecto OMRP
Duración del proyecto: 25 meses
Fecha Inicio: 2023-07-01
Fecha Fin: 2025-08-31
Líder del proyecto
KEMIJSKI INSTITUT
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
O-GlcNAcylation is a post-translational dynamic modification of proteins that is becoming more widely recognized as a modification that can protect proteins from pathological aggregation in neurodegenerative diseases. However, it is unknown how this modification influences the RNA binding properties of the protein and its function. In the proposed project I will study the O-Glc-NAcylation of RNA-binding proteins (RBPs) associated with amyotrophic lateral sclerosis (ALS), and its effects on the RNA binding properties and thereby on the regulation of RNA processing. I will find O-GlcNAcylation sites of TDP-43, Fused-in-sarcoma (FUS), Ewing sarcoma protein (EWS), and TATA-box binding protein associated factor 15 (TAF15) and I will assess the increased amounts of modification after stimulation of the cells with high glucose or with O-Glc-NAcase inhibitor. I will study if their RNA interaction profiles change with increasing amounts of O-Glc-NAc modifications in differentiated cortical neurons. Later, I plan to implement in the company, a mass spectrometry method adapted to analyse the ALS-liked RBPs proteins, which will help the glycoscience community. This project will expand our understanding of the molecular mechanism of transcription regulation through protein O-Glc-NAcylation and can provide the necessary knowledge to understand ALS-related proteinopathies.